RESUMEN
Fifty years ago, bacteria in the genus Brucella were known to cause infertility and reproductive losses. At that time, the genus was considered to contain only 3 species: Brucella abortus, Brucella melitensis, and Brucella suis. Since the early 1960s, at least 7 new species have been identified as belonging to the Brucella genus (Brucella canis, Brucella ceti, Brucella inopinata, Brucella microti, Brucella neotomae, Brucella ovis, and Brucella pinnipedialis) with several additional new species under consideration for inclusion. Although molecular studies have found such high homology that some authors have proposed that all Brucella are actually 1 species, the epidemiologic and diagnostic benefits for separating the genus based on phenotypic characteristics are more compelling. Although pathogenic Brucella spp have preferred reservoir hosts, their ability to infect numerous mammalian hosts has been increasingly documented. The maintenance of infection in new reservoir hosts, such as wildlife, has become an issue for both public health and animal health regulatory personnel. Since the 1960s, new information on how Brucella enters host cells and modifies their intracellular environment has been gained. Although the pathogenesis and histologic lesions of B. abortus, B. melitensis, and B. suis in their preferred hosts have not changed, additional knowledge on the pathology of these brucellae in new hosts, or of new species of Brucella in their preferred hosts, has been obtained. To this day, brucellosis remains a significant human zoonosis that is emerging or reemerging in many parts of the world.
Asunto(s)
Vacuna contra la Brucelosis/inmunología , Brucella/fisiología , Brucelosis/microbiología , Animales , Animales Salvajes , Brucella/clasificación , Brucella/patogenicidad , Brucelosis/transmisión , Enfermedades Transmisibles Emergentes/microbiología , Enfermedades Transmisibles Emergentes/transmisión , Modelos Animales de Enfermedad , Reservorios de Enfermedades , Humanos , ZoonosisRESUMEN
Bovine respiratory syncytial virus (RSV) is a cause of respiratory disease in cattle worldwide. It has an integral role in enzootic pneumonia in young dairy calves and summer pneumonia in nursing beef calves. Furthermore, bovine RSV infection can predispose calves to secondary bacterial infection by organisms such as Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni, resulting in bovine respiratory disease complex, the most prevalent cause of morbidity and mortality among feedlot cattle. Even in cases where animals do not succumb to bovine respiratory disease complex, there can be long-term losses in production performance. This includes reductions in feed efficiency and rate of gain in the feedlot, as well as reproductive performance, milk production, and longevity in the breeding herd. As a result, economic costs to the cattle industry from bovine respiratory disease have been estimated to approach $1 billion annually due to death losses, reduced performance, and costs of vaccinations and treatment modalities. Human and bovine RSV are closely related viruses with similarities in histopathologic lesions and mechanisms of immune modulation induced following infection. Therefore, where appropriate, we provide comparisons between RSV infections in humans and cattle. This review article discusses key aspects of RSV infection of cattle, including epidemiology and strain variability, clinical signs and diagnosis, experimental infection, gross and microscopic lesions, innate and adaptive immune responses, and vaccination strategies.
Asunto(s)
Enfermedades de los Bovinos/epidemiología , Infecciones por Virus Sincitial Respiratorio/veterinaria , Virus Sincitiales Respiratorios/inmunología , Vacunas Virales , Inmunidad Adaptativa , Animales , Bovinos , Enfermedades de los Bovinos/diagnóstico , Enfermedades de los Bovinos/inmunología , Inmunidad Innata , Infecciones por Virus Sincitial Respiratorio/diagnóstico , Infecciones por Virus Sincitial Respiratorio/epidemiología , Infecciones por Virus Sincitial Respiratorio/inmunología , Virus Sincitiales Respiratorios/patogenicidadRESUMEN
The golden Syrian hamster (Mesocricetus auratus) is frequently used as a model to study virulence for several Leptospira species. Onset of an acute lethal infection following inoculation with several pathogenic Leptospira species has been widely adopted for pathogenesis studies. An important exception is the outcome following inoculation of hamsters with live L. borgpetersenii serovar Hardjo, the primary cause of bovine leptospirosis and a cause of human infections. Typically, inoculation of hamsters with L. borgpetersenii serovar Hardjo fails to induce clinical signs of infection. In this study, the authors defined LD(50) and ID(50) for 2 strains of L. borgpetersenii serovar Hardjo: JB197 and 203. Both strains infected hamsters with ID(50) values of approximately 1.5 × 10(2) bacteria yet differed in tissue invasion and interaction with leukocytes, resulting in widely divergent clinical outcomes. Hamsters infected with strain 203 established renal colonization within 4 days postinfection and remained asymptomatic with chronic renal infections similar to cattle infected with serovar Hardjo. In contrast, hamsters infected with strain JB197 developed a rapidly debilitating disease typical of acute leptospirosis common in accidental hosts (eg, humans) with an LD(50) of 3.6 × 10(4) bacteria. Evidence that strain JB197 resides in both extracellular and intracellular environments during hamster infection was obtained. Development of models that result in chronic and acute forms of leptospirosis provides a platform to study L. borgpetersenii pathogenesis and to test vaccines for the prevention of leptospirosis.
Asunto(s)
Enfermedades de los Bovinos/microbiología , Modelos Animales de Enfermedad , Leptospira/patogenicidad , Leptospirosis/patología , Leucocitos/microbiología , Mesocricetus , Animales , Bovinos , Enfermedades de los Bovinos/patología , Cricetinae , Femenino , Interacciones Huésped-Patógeno , Humanos , Inyecciones Intraperitoneales/veterinaria , Leptospirosis/microbiología , Dosificación Letal Mediana , Masculino , Especificidad de Órganos , VirulenciaRESUMEN
Mycobacterium bovis (M. bovis) is the zoonotic bacterium responsible for bovine tuberculosis. An attenuated form of M. bovis, Bacillus Calmette-Guerin (BCG), is a modified live vaccine known to provide variable protection in cattle and other species. Protection for this vaccine is defined as a reduction in disease severity rather than prevention of infection and is determined by evaluation of the characteristic lesion of tuberculosis: the granuloma. Despite its recognized ability to decrease disease severity, the mechanism by which BCG imparts protection remains poorly understood. Understanding the histopathologic differences between granulomas which form in BCG vaccinates compared to non-vaccinates may help identify how BCG imparts protection and lead to an improved vaccine. Utilizing special stains and image analysis software, we examined 88 lymph nodes obtained from BGC-vaccinated and non-vaccinated animals experimentally infected with M. bovis. We evaluated the number of granulomas, their size, severity (grade), density of multinucleated giant cells (MNGC), and the amounts of necrosis, mineralization, and fibrosis. BCG vaccinates had fewer granulomas overall and smaller high-grade granulomas with less necrosis than non-vaccinates. The relative numbers of high- and low- grade lesions were similar as were the amounts of mineralization and the density of MNGC. The amount of fibrosis was higher in low-grade granulomas from vaccinates compared to non-vaccinates. Collectively, these findings suggest that BCG vaccination reduces bacterial establishment, resulting in the formation of fewer granulomas. In granulomas that form, BCG has a protective effect by containing their size, reducing the relative amount of necrosis, and increasing fibrosis in low-grade lesions. Vaccination did not affect the amount of mineralization or density of MNGC.
RESUMEN
In the present study, calves were infected with Mycobacterium avium subsp. paratuberculosis (MAP), Mycobacterium avium subsp. avium (M. avium), Mycobacterium kansasii (M. kansasii), or Mycobacterium bovis (M. bovis) to determine differences in cellular immunity. Comparative cellular responses were assessed upon stimulation of cells with mycobacterial whole cell sonicates respective of each infection group. Antigen-specific whole blood interferon gamma (IFN-γ) responses were observed in all infection groups compared to noninfected control calves, however, responses were more robust for M. bovis calves. Upon antigen stimulation of PBMCs, secretion of IFN-γ and IL-10 was higher for M. bovis calves compared to other infection groups. In contrast, IL-12 secretion was lower for M. bovis calves compared to MAP infected calves. Within the total PBMC population, higher numbers of CD4+, CD8+, and γδ TCR + T cells were observed for MAP and M. avium calves compared to M. bovis calves. This aligned with higher expression of CD26 on these subpopulations for MAP and M. avium calves, as well. In contrast, greater expression of CD25 was observed on CD4+ and γδ TCR + T cells and natural killer cells for M. bovis calves. Overall, similarities in cellular immune responses were observed between the closely related MAP and M. avium during infection of calves. In contrast, significant differences were noted between calves infected with MAP and M. bovis. This suggests that host immune responses to different mycobacteria may impact interpretation of diagnostic tools based upon their cellular immunity.
Asunto(s)
Enfermedades de los Bovinos/microbiología , Inmunidad Celular , Infecciones por Mycobacterium/veterinaria , Animales , Bovinos , Enfermedades de los Bovinos/inmunología , Reacciones Cruzadas , Citocinas/inmunología , Citometría de Flujo/veterinaria , Interferón gamma/inmunología , Subgrupos Linfocitarios/inmunología , Masculino , Mycobacterium/inmunología , Infecciones por Mycobacterium/inmunología , Infecciones por Mycobacterium/microbiología , Mycobacterium avium subsp. paratuberculosis/inmunología , Mycobacterium bovis/inmunología , Mycobacterium kansasii/inmunología , Especificidad de la EspecieRESUMEN
Understanding the host response to Mycobacterium avium subsp. paratuberculosis is critical to the development of effective vaccines and therapeutics for the control of this disease in the field. The current study compared the effectiveness of oral and intraperitoneal (IP) methods of experimental inoculation and two strains of M. avium subsp. paratuberculosis (strain K-10 and clinical isolate 509) on the level of infection and lesion development. Calves were inoculated with 4x10(11) to 8x10(12)cfu live bacteria, depending upon treatment group. Fecal shedding of M. avium subsp. paratuberculosis was minimal and infrequent over the course of the study for calves that received strain K-10 (oral and IP), however, calves orally inoculated with the clinical isolate shed high numbers of bacteria in their feces up to 4 months post-inoculation. Colonization was present in a number of intestinal tissues and lymph nodes with the lowest number of affected tissues in the IP calves and the highest for calves receiving the clinical isolate via oral inoculation. Microscopic lesions were predominantly found in the ileal and jejunal sections of small intestine and their associated lymph nodes, as well as the ileocecal valve and node. These data suggest that a variety of experimental infection regimes can be effective but oral inoculation with a clinical isolate may result in greater colonization of tissues and fecal shedding of M. avium subsp. paratuberculosis.
Asunto(s)
Enfermedades de los Bovinos/microbiología , Enfermedades Intestinales/veterinaria , Mycobacterium avium subsp. paratuberculosis/fisiología , Paratuberculosis/microbiología , Animales , Animales Recién Nacidos , Bovinos , Recuento de Colonia Microbiana , ADN Bacteriano/química , ADN Bacteriano/genética , Dexametasona/farmacología , Modelos Animales de Enfermedad , Heces/microbiología , Femenino , Genotipo , Histocitoquímica/veterinaria , Interacciones Huésped-Patógeno , Enfermedades Intestinales/microbiología , Mycobacterium avium subsp. paratuberculosis/patogenicidad , Reacción en Cadena de la Polimerasa/veterinariaRESUMEN
Complex interactions involving humans, domestic animals, and wildlife create environments favorable to the emergence of new diseases. Today, reservoirs of Mycobacterium bovis, the causative agent of tuberculosis in animals and a serious zoonosis, exist in wildlife. The presence of these wildlife reservoirs is the direct result of spillover from domestic livestock in combination with anthropogenic factors such as translocation of wildlife, supplemental feeding of wildlife and wildlife populations reaching densities beyond normal habitat carrying capacities. As many countries attempt to eradicate M. bovis from domestic livestock, efforts are impeded by spillback from wildlife reservoirs. It will not be possible to eradicate M. bovis from livestock until transmission between wildlife and domestic animals is halted. Such an endeavor will require a collaborative effort between agricultural, wildlife, environmental and political interests.
Asunto(s)
Enfermedades Transmisibles Emergentes/veterinaria , Mycobacterium bovis , Tuberculosis/transmisión , Tuberculosis/veterinaria , Zoonosis , Animales , Animales Domésticos/microbiología , Animales Salvajes/microbiología , Control de Enfermedades Transmisibles , Enfermedades Transmisibles Emergentes/epidemiología , Enfermedades Transmisibles Emergentes/microbiología , Enfermedades Transmisibles Emergentes/transmisión , Reservorios de Enfermedades/microbiología , Reservorios de Enfermedades/veterinaria , Humanos , Italia/epidemiología , Nueva Zelanda/epidemiología , España/epidemiología , Tuberculosis/epidemiología , Tuberculosis/microbiología , Reino Unido/epidemiología , Estados Unidos/epidemiologíaRESUMEN
Coinfection with two or more pathogens is a common occurrence in respiratory diseases of most species. The manner in which multiple pathogens interact is not always straightforward, however. Bordetella bronchiseptica and porcine respiratory coronavirus (PRCV) are respiratory pathogens of pigs whose relatives, B. pertussis and the SARS virus, cause respiratory disease in humans. In an initial experiment, the effect of coinfection of PRCV and B. bronchiseptica was examined in thirty, 4-week-old pigs (10 pigs/group) that were infected with either PRCV or B. bronchiseptica, or both PRCV and B. bronchiseptica. An additional 10 pigs served as sham infected controls. Five pigs from each group were euthanized at 4 and 10 days post-infection. Gross and histopathological lung lesions were more severe in the coinfected group as compared to the groups infected with B. bronchiseptica or PRCV alone. In order to investigate the potential role of proinflammatory cytokines in disease severity after coinfection, a second experiment was performed to examine cytokine transcription in alveolar macrophages from single and dually infected pigs. A total of 48 pigs were divided equally into groups as above, but 4 pigs from each group were euthanized at 1, 4 and 10 days post-infection. Coinfected pigs showed a greater and more sustained transcription of proinflammatory cytokines, especially IL-6 and MCP-1, than pigs infected with either PRCV or B. bronchiseptica alone. Thus, there appears to be a synergistic effect between PRCV and B. bronchiseptica with regards to proinflammatory cytokine transcription that may partially explain the increased severity of pneumonia in coinfected pigs.
Asunto(s)
Infecciones por Bordetella/veterinaria , Bordetella bronchiseptica , Infecciones por Coronavirus/veterinaria , Coronavirus Respiratorio Porcino , Infecciones del Sistema Respiratorio/veterinaria , Enfermedades de los Porcinos/patología , Animales , Infecciones por Bordetella/complicaciones , Infecciones por Bordetella/patología , Bordetella bronchiseptica/aislamiento & purificación , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/patología , Citocinas/análisis , Citocinas/biosíntesis , Citocinas/genética , Expresión Génica/inmunología , Pulmón/inmunología , Pulmón/patología , Macrófagos Alveolares/química , Macrófagos Alveolares/inmunología , Coronavirus Respiratorio Porcino/aislamiento & purificación , Distribución Aleatoria , Infecciones del Sistema Respiratorio/microbiología , Infecciones del Sistema Respiratorio/patología , Infecciones del Sistema Respiratorio/virología , Porcinos , Enfermedades de los Porcinos/microbiología , Enfermedades de los Porcinos/virología , Factores de TiempoRESUMEN
Numerous species of mammals are susceptible to Mycobacterium bovis, the causative agent of bovine tuberculosis (TB). Several wildlife hosts have emerged as reservoirs of M. bovis infection for domestic livestock in different countries. In the present study, blood samples were collected from Eurasian badgers (n=1532), white-tailed deer (n=463), brushtail possums (n=129), and wild boar (n=177) for evaluation of antibody responses to M. bovis infection by a lateral-flow rapid test (RT) and multiantigen print immunoassay (MAPIA). Magnitude of the antibody responses and antigen recognition patterns varied among the animals as determined by MAPIA; however, MPB83 was the most commonly recognized antigen for each host studied. Other seroreactive antigens included ESAT-6, CFP10, and MPB70. The agreement of the RT with culture results varied from 74% for possums to 81% for badgers to 90% for wild boar to 97% for white-tailed deer. Small numbers of wild boar and deer exposed to M. avium infection or paratuberculosis, respectively, did not cross-react in the RT, supporting the high specificity of the assay. In deer, whole blood samples reacted similarly to corresponding serum specimens (97% concordance), demonstrating the potential for field application. As previously demonstrated for badgers and deer, antibody responses to M. bovis infection in wild boar were positively associated with advanced disease. Together, these findings suggest that a rapid TB assay such as the RT may provide a useful screening tool for certain wildlife species that may be implicated in the maintenance and transmission of M. bovis infection to domestic livestock.
Asunto(s)
Animales Salvajes/microbiología , Mycobacterium bovis/aislamiento & purificación , Pruebas Serológicas/veterinaria , Tuberculosis Bovina/epidemiología , Animales , Animales Salvajes/sangre , Anticuerpos Antibacterianos/inmunología , Antígenos Bacterianos/inmunología , Bovinos , Ciervos/sangre , Ciervos/microbiología , Mustelidae/sangre , Mustelidae/microbiología , Nueva Zelanda/epidemiología , Portugal/epidemiología , España/epidemiología , Sus scrofa/sangre , Sus scrofa/microbiología , Trichosurus/sangre , Trichosurus/microbiología , Tuberculosis Bovina/sangre , Reino Unido/epidemiología , Estados Unidos/epidemiologíaRESUMEN
We investigated the efficacy of oral and parenteral Mycobacterium bovis bacille Calmette-Guerin Danish strain 1331 (BCG) in its ability to protect white-tailed deer (Odocoileus virginianus) against disease caused by M. bovis infection. Twenty-two white-tailed deer were divided into four groups. One group (n=5) received 10(9) colony-forming units (cfu) BCG via a lipid-formulated oral bait; one group (n=5) received 10(9) cfu BCG in culture directly to the oropharynx, one group (n=6) was vaccinated with 10(6) cfu BCG subcutaneously, and one group served as a control and received culture media directly to the oropharynx (n=6). All animals were challenged 3 mo after vaccination. Five months postchallenge the animals were examined for lesions. Results indicate that both oral forms of BCG and parenterally administered BCG offered significant protection against M. bovis challenge as compared to controls. This study suggests that oral BCG vaccination may be a feasible means of controlling bovine tuberculosis in wild white-tailed deer populations.
Asunto(s)
Vacuna BCG/administración & dosificación , Ciervos/inmunología , Mycobacterium bovis/inmunología , Tuberculosis/veterinaria , Vacunación/veterinaria , Administración Oral , Animales , Recuento de Colonia Microbiana/veterinaria , Ciervos/microbiología , Estudios de Factibilidad , Femenino , Infusiones Parenterales/veterinaria , Distribución Aleatoria , Resultado del Tratamiento , Tuberculosis/prevención & control , Vacunación/métodosRESUMEN
Mitogen- and antigen-induced interferon-gamma (IFN-gamma) responses of peripheral blood leucocytes from cervids were evaluated by a commercial whole-blood assay. The assay was applied to Mycobacterium bovis-infected white-tailed deer and reindeer, M bovis BCG-vaccinated white-tailed deer and elk, and unvaccinated, uninfected white-tailed deer, fallow deer, elk and reindeer. The responses of the M bovis-infected white-tailed deer to pokeweed mitogen (PWM) varied with time and between individuals. The responses of the M bovis-infected reindeer to PWM and M bovis purified protein derivative (PPD) were positively associated. Samples from tuberculosis-free captive herds in various parts of the USA were also evaluated. Four per cent of fallow deer, 20 per cent of elk, 44 per cent of white-tailed deer, and 91 per cent of reindeer had responses to PWM exceeding 0.25 Delta optical density, that is, PWM stimulation minus no stimulation. The specificity of the responses to M bovis PPD and a Mycobacterium tuberculosis complex-specific antigen rESAT-6:CFP-10, excluding animals not responding to PWM, ranged from 78 per cent to 100 per cent and was dependent upon the species and the positive response cut-off value. The results show that the commercial assay is valid for the detection of TB in reindeer; however, further development of the assay will be required before it is used in surveillance programmes for white-tailed deer, fallow deer, and elk.
Asunto(s)
Antígenos Bacterianos/inmunología , Vacuna BCG/inmunología , Ciervos , Interferón gamma/biosíntesis , Mycobacterium bovis/inmunología , Tuberculosis/veterinaria , Animales , Concanavalina A/farmacología , Ciervos/inmunología , Ciervos/microbiología , Femenino , Leucocitos , Activación de Linfocitos , Masculino , Fitohemaglutininas/farmacología , Mitógenos de Phytolacca americana/farmacología , Reno/inmunología , Reno/microbiología , Tuberculosis/sangre , Tuberculosis/diagnóstico , Tuberculosis/inmunología , Vacunación/veterinariaRESUMEN
The Bovigam assay is approved for use within the United States as a complementary tuberculosis test. Prior to whole blood culture and the ensuing ELISA to detect interferon-(IFN)-gamma, samples are subjected to various holding time/temperature combinations due, in part, to practical constraints associated with shipment of samples to approved laboratories. To evaluate these effects, 5-month-old Holstein calves (n = 7) received 10(3) cfu Mycobacterium bovis by aerosol. Heparinized blood was collected 2 months after challenge and held at 4 or 22 degrees C for 0, 8 or 24 h prior to culture with mycobacterial antigens or pokeweed mitogen (PWM). Responses of samples held for 8 or 24 h were comparable and lower than responses of cultures prepared immediately after collection, regardless of holding temperature. Differences in responses of samples held at 4 degrees C versus 22 degrees C were also minimal. A subset of samples was held for 2 h at 37 degrees C at the beginning of the holding period. This subset of samples had diminished responses to all stimulants and increased holding times (i.e., 24 h versus 8 h) negatively impacted the response. Pre-processing conditions, particularly delays in set-up and initial high sample temperatures, reduces IFN-gamma responses of cells from infected cattle increasing the risk of false negatives in this assay of regulatory importance.
Asunto(s)
Interferón gamma/análisis , Mycobacterium bovis/inmunología , Manejo de Especímenes/veterinaria , Tuberculosis Bovina/diagnóstico , Animales , Bovinos , Células Cultivadas , Interferón gamma/biosíntesis , Masculino , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Manejo de Especímenes/normas , Temperatura , Factores de Tiempo , Prueba de Tuberculina/métodos , Prueba de Tuberculina/veterinaria , Tuberculosis Bovina/sangreRESUMEN
During an 18-mo period (May 2002-November 2003), 10 animals in a herd of 19 reindeer (Rangifer tarandus) at the National Animal Disease Center (NADC) experienced episodes of anemia. Affected animals had histories of weight loss, unthriftiness, occasionally edema of dependent parts and moderate anemia characterized by microcytosis or macrocytosis, hypochromasia, schistocytosis, keratocytosis, acanthocytosis, and dacryocytosis. Numerous basophilic punctate to ring-shaped bodies, measuring less than 1.0 microm, were found on the surface of red blood cells and were often observed encircling the outer margins of the cells. Based on cytologic findings, DNA preparations from selected affected animals in the NADC herd and one animal from a private herd experiencing similar episodes of anemia were assayed by polymerase chain reaction (PCR) for the presence of hemotropic bacteria using primers targeting the 16S rRNA genes of Mycoplasma (Eperythrozoon) suis, Mycoplasma (Haemobartonella) haemofelis, Anaplasma marginale, Anaplasma spp., and Ehrlichia spp. Amplification products were detected from four of the affected animals using primers specific for the 16S rRNA gene of M. haemofelis and Mycoplasma haemocanis. Product from one of the animals was sequenced and internal primers were designed from the resulting sequence to perform a nested PCR assay. Samples from 10 reindeer were positive using the nested PCR reaction and products from seven animals were sequenced; BLAST searches and phylogenetic analysis were performed on the resulting sequences. Sequence data from six animals revealed homology to an organism most closely related to Mycoplasma ovis, Mycoplasma wenyonii, and Mycoplasma haemolamae; sequence from a single animal was most closely related to M. haemofelis and M. haemocanis. This represents the first identification of a haemomycoplasma species in reindeer. Although several animals were also infected with abomasal nematodes, the presence of this newly described haemomycoplasma may have contributed to the anemic syndrome.
Asunto(s)
Anaplasma/aislamiento & purificación , Anemia/veterinaria , Ehrlichia/aislamiento & purificación , Mycoplasma/aislamiento & purificación , Reno/microbiología , Anaplasma/clasificación , Anaplasma/genética , Anemia/diagnóstico , Anemia/microbiología , Animales , Animales Salvajes , Secuencia de Bases , Ehrlichia/clasificación , Ehrlichia/genética , Femenino , Amplificación de Genes , Masculino , Mycoplasma/clasificación , Mycoplasma/genética , Filogenia , Reacción en Cadena de la Polimerasa/métodos , Reacción en Cadena de la Polimerasa/veterinaria , ARN Ribosómico 16S/análisis , Reno/sangreRESUMEN
Mycobacterium bovis is the cause of tuberculosis in most animal species including cattle and is a serious zoonotic pathogen. In man, M. bovis infection can result in disease clinically indistinguishable from that caused by Mycobacterium tuberculosis, the cause of most human tuberculosis. Regardless of host, the typical lesion induced by M. bovis or M. tuberculosis is the tuberculoid granuloma. Tuberculoid granulomas are dynamic structures reflecting the interface between host and pathogen and, therefore, pass through various morphological stages (I to IV). Using a novel in-situ hybridization assay, transcription of various cytokine and chemokine genes was examined qualitatively and quantitatively using image analysis. In experimentally infected cattle, pulmonary granulomas of all stages were examined 150 days after aerosol exposure to M. bovis. Expression of mRNA encoding tumour necrosis factor (TNF)-α, transforming growth factor-ß, interferon (IFN)-γ, interleukin (IL)-17A, IL-16, IL-10, CXCL9 and CXCL10 did not differ significantly between granulomas of different stages. However, relative expression of the various cytokines was characteristic of a Th1 response, with high TNF-α and IFN-γ expression and low IL-10 expression. Expression of IL-16 and the chemokines CXCL9 and CXCL10 was high, suggestive of granulomas actively involved in T-cell chemotaxis.
Asunto(s)
Citocinas/biosíntesis , Perfilación de la Expresión Génica/métodos , Granuloma del Sistema Respiratorio/inmunología , Hibridación in Situ/métodos , Tuberculosis Bovina/inmunología , Animales , Bovinos , Compuestos Cromogénicos , Citocinas/análisis , Granuloma del Sistema Respiratorio/patología , Masculino , Mycobacterium bovis , Transcriptoma , Tuberculosis Bovina/patología , Tuberculosis Pulmonar/inmunología , Tuberculosis Pulmonar/patologíaRESUMEN
SETTING: White-tailed deer represent the first wildlife reservoir of Mycobacterium bovis in the United States. The behavior of does with nursing fawns provides several potential mechanisms for disease transmission. Little information exists concerning transmission between doe and fawn, specifically transmammary transmission. OBJECTIVE: Determine if fawns can become infected by ingestion of milk replacer containing M. bovis, thus simulating transmission from doe to fawn through contaminated milk. DESIGN: Seventeen, 21-day-old white-tailed deer fawns were inoculated orally with 2 x 10(8) CFU (high dose, n=5), 2.5 x 10(5) to 2.5 x 10(6) CFU (medium dose, n=5), and 1 x 10(4) CFU (low dose, n=5) of M. bovis in milk replacer. Dosages were divided equally and fed daily over a 5-day period. Positive control fawns (n=2) received 1 x 10(5) CFU of M. bovis instilled in the tonsillar crypts. Fawns were euthanized and examined 35-115 days after inoculation and various tissues collected for bacteriologic and microscopic analysis. RESULTS: All fawns in the tonsillar, high oral and medium oral dose groups developed generalized tuberculosis involving numerous organs and tissues by 35-84 days after inoculation. Three of five fawns in the low-dose oral group had tuberculous lesions in the mandibular lymph node, and one of five had lesions in the medial retropharyngeal lymph node when examined 115 days after inoculation. CONCLUSION: White-tailed deer fawns can become infected through oral exposure to M. bovis. Therefore, the potential exists for fawns to acquire M. bovis while nursing tuberculous does.
Asunto(s)
Ciervos/microbiología , Leche/microbiología , Mycobacterium bovis/aislamiento & purificación , Tuberculosis/veterinaria , Animales , Animales Recién Nacidos , Femenino , Masculino , Tuberculosis/patología , Tuberculosis/transmisión , Tuberculosis Gastrointestinal/patología , Tuberculosis Gastrointestinal/veterinaria , Tuberculosis Ganglionar/patología , Tuberculosis Ganglionar/veterinaria , Tuberculosis Pulmonar/patología , Tuberculosis Pulmonar/veterinariaRESUMEN
SETTING: Although animal models of aerosol inoculation of Mycobacterium tuberculosis and M. bovis have been reported using laboratory animals, a model of aerosol delivery of M. bovis to cattle has not been reported previously. OBJECTIVE: Develop and characterize a model of aerosol delivery of M. bovis to cattle, and compare the distribution of lesions in cattle infected with either of two different strains of M. bovis, one isolated from cattle (HC2005T), and the other isolated from white-tailed deer (1315). DESIGN: Cattle (n=20, female and castrated males) aged 4 months, were infected with 1 x 10(3) (n=5) or 1 x 10(5) (n=5) colony-forming units (CFU) of M. bovis 1315 or 1 x 10(3) (n=5) or 1x10(5) (n=5) CFU of M. bovis HC2005T. Calves were infected using a commercially available aerosol delivery system. One hundred fifty-five days after infection, calves were euthanized, examined and tissues collected for microscopic analysis and bacteriologic culture. RESULTS: Nineteen of 20 calves developed tuberculosis. Typical tuberculous lesions were most pronounced in the lungs and tracheobronchial and mediastinal lymph nodes. CONCLUSION: The system described provides a reliable method of aerosol delivery of M. bovis to cattle. Lesion distribution suggests that the aerosolized inoculum was delivered deep into pulmonary alveoli and thus represents true aerosol exposure. Disease was more severe in groups receiving the highest dose of either inoculum strain; however, differences between strains were not seen. Published by Elsevier Science Ltd.
Asunto(s)
Modelos Animales de Enfermedad , Mycobacterium bovis , Tuberculosis Bovina/transmisión , Aerosoles , Animales , Bovinos , Femenino , Granuloma/microbiología , Masculino , Tuberculosis Bovina/patologíaRESUMEN
SETTING: 1,25-dihydroxyvitamin D3 (1,25(OH)(2)D(3)) is a potent modulator of immune responses and may be beneficial in the treatment of tuberculosis. Recent evidence suggest that 1,25(OH)(2)D(3) may affect T-dependent responses in cattle; however, mechanisms by which this vitamin modulates activation of bovine T cells are unclear. OBJECTIVE: Determine the effects of 1,25(OH)(2)D(3) on the expression of CD25, CD44, and CD62L by bovine T cell subsets proliferating in response to antigen stimulation. DESIGN: Antigen-specific recall responses of Mycobacterium bovis bacille Calmette-Guerin (BCG) vaccinated cattle were used as a model system to evaluate effects of 1,25(OH)(2)D(3) on the proliferation and activation of bovine T cell subsets. RESULTS: CD4(+) and gamma delta TCR(+) cells were the predominant T cell subsets responding to soluble crude M. bovis-derived antigens (i.e., purified protein derivative and a BCG whole cell sonicate) by proliferation and activation-induced alterations in phenotype. These subsets exhibited increased CD25 and CD44 mean fluorescence intensity (mfi) and decreased CD62L mfi upon antigen stimulation. Addition of 1,25(OH)(2)D(3) inhibited proliferation of CD4(+) cells and decreased the expression of CD44 on responding (i.e., proliferating) CD4(+) and gamma delta TCR(+) cells. CONCLUSION: These findings suggest that the production of 1,25(OH)(2)D(3) by macrophages within tuberculous lesions would inhibit proliferation and CD44 expression by co-localized CD4(+) and gamma delta TCR(+) cells.
Asunto(s)
Vacuna BCG/inmunología , Calcitriol/farmacología , Activación de Linfocitos/efectos de los fármacos , Tuberculosis Bovina/inmunología , Animales , Linfocitos T CD4-Positivos/inmunología , Bovinos , División Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Receptores de Hialuranos/metabolismo , Selectina L/metabolismo , Activación de Linfocitos/inmunología , Receptores de Antígenos de Linfocitos T gamma-delta/metabolismo , Receptores de Interleucina-2/metabolismo , VacunaciónRESUMEN
Despite highly successful eradication efforts in several countries, Mycobacterium bovis infection of cattle remains a significant health concern worldwide. Immune mechanisms of resistance to and/or clearance of M. bovis infection of cattle, however, are unclear. Recent studies have provided evidence supporting a role for CD4(+), CD8(+), and gammadelta TCR(+) T cells in the response of cattle to M. bovis. In the present study, we utilized a flow cytometric-based proliferation assay to determine the relative contribution of individual lymphocyte subsets in the response to M. bovis infection and/or sensitization with mycobacterial purified protein derivative (PPD). Peripheral blood mononuclear cells (PBMC) from M. bovis-infected cattle proliferated in response to in vitro stimulation with M. bovis PPD. CD4(+) T cells and gammadelta TCR(+) cells were the predominate subsets of lymphocytes responding to PPD. gammadelta TCR(+) cells also proliferated in non-stimulated cultures; however, the gammadelta TCR(+) cell proliferative response of infected cattle was significantly (p<0.05) greater in PPD-stimulated cultures as compared to non-stimulated cultures. Intradermal injection of PPD for comparative cervical testing (CCT) induced a boost in the in vitro proliferative response of CD4(+) but not gammadelta TCR(+) cells of infected cattle. Administration of PPD for CCT also boosted interferon-gamma (IFN-gamma) production by PBMC of infected cattle following in vitro stimulation with M. bovis PPD. Injection of PPD for CCT did not, however, elicit a proliferative or IFN-gamma response in cells isolated from non-infected cattle. These data indicate that CD4(+) and gammadelta TCR(+) cells of M. bovis-infected cattle proliferate in a recall response to M. bovis PPD and that the CD4(+) cell response is boosted by intradermal injection with PPD for CCT.
Asunto(s)
Activación de Linfocitos , Subgrupos de Linfocitos T/inmunología , Tuberculina/inmunología , Tuberculosis Bovina/inmunología , Animales , Linfocitos T CD4-Positivos/inmunología , Bovinos , Interferón gamma/biosíntesis , Receptores de Antígenos de Linfocitos T gamma-delta/análisisRESUMEN
White-tailed deer are significant wildlife reservoirs of Mycobacterium bovis for cattle, predators, and, potentially, humans. Infection of cattle with M. bovis stimulates an antigen-specific T-cell response, with both CD4(+) and CD8(+) cells implicated in protective immunity. Few studies, however, have examined lymphocyte subset responses to experimental M. bovis infection of white-tailed deer. In this study, a flow cytometric proliferation assay was used to determine the relative contribution of individual peripheral blood mononuclear cell subsets of M. bovis-infected white-tailed deer in the recall response to M. bovis antigen. Naive deer were challenged with M. bovis by cohabitation with infected deer. These M. bovis-challenged deer developed significant in vivo (delayed-type hypersensitivity) and in vitro (proliferative) responses to M. bovis purified protein derivative (PPD). At necropsy, typical tuberculous lesions containing M. bovis were detected within lungs and lung-associated lymph nodes of infected deer. The predominant subset of lymphocytes that proliferated in response to in vitro stimulation with PPD was the CD4(+) subset. Minimal proliferative responses were detected from CD8(+), gamma delta TCR(+), and B-cells. Addition of monoclonal antibodies specific for MHC II antigens, but not MHC I or CD1 antigens, abrogated the proliferative response. Together, these findings indicate that while CD4(+) cells from infected deer proliferate in the recall response to M. bovis antigens, this response is not sufficient to clear M. bovis and immunologic intervention may require stimulation of alternate subsets of lymphocytes.
Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Ciervos/inmunología , Reservorios de Enfermedades/veterinaria , Complejo Mayor de Histocompatibilidad/inmunología , Mycobacterium bovis/inmunología , Subgrupos de Linfocitos T/inmunología , Tuberculosis/veterinaria , Animales , Anticuerpos Monoclonales/inmunología , Especificidad de Anticuerpos , División Celular/inmunología , Ciervos/microbiología , Femenino , Citometría de Flujo/veterinaria , Antígenos de Histocompatibilidad Clase II/inmunología , Hipersensibilidad Tardía/inmunología , Hipersensibilidad Tardía/veterinaria , Activación de Linfocitos/inmunología , Masculino , Mycobacterium bovis/crecimiento & desarrollo , Subgrupos de Linfocitos T/microbiología , Tuberculosis/inmunología , Tuberculosis/transmisiónRESUMEN
The comparative cervical skin test for antemortem diagnosis of tuberculosis was done 169 times on 116 different white-tailed deer of known Mycobacterium bovis infection status. The sensitivity and specificity were 97 and 81%, respectively. The magnitude of change in skin thickness at test sites was not significantly influenced by dosage of inoculum, dissemination of the disease process, or repeated skin testing. However, the magnitude of change in skin thickness was significantly greater in deer infected for less than 109 days than in deer infected for more than 109 days. As used in the present study, the comparative cervical skin test is a sensitive method of antemortem diagnosis of M. bovis infection in white-tailed deer.